1. LOXL2 is a prognosis biomarker and a potential therapeutic target in intrahepatic cholangiocarcinoma. (April 2016) Authors: Bergeat, D.; Fautrel, A.; Turlin, B.; Merdrignac, A.; Rayar, M.; Meunier, B.; Clement, B.; Boudjema, K.; Coulouarn, C.; Sulpice, L. Journal: HPB Issue: Volume 18(2016)Supplement 2 Page Start: e863 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗